Functional characterization of two novel germline mutations of the KCNJ5 gene in hypertensive patients without primary aldosteronism but with ACTH-dependent aldosterone hypersecretion.

Familial hyperaldosteronism type III. J Hum Hypertens (2017) 0.75

GROMACS 4:  Algorithms for Highly Efficient, Load-Balanced, and Scalable Molecular Simulation. J Chem Theory Comput (2008) 34.90

AQUA and PROCHECK-NMR: programs for checking the quality of protein structures solved by NMR. J Biomol NMR (1996) 29.55

GROMACS: fast, flexible, and free. J Comput Chem (2005) 27.22

VERIFY3D: assessment of protein models with three-dimensional profiles. Methods Enzymol (1997) 6.71

Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline. J Clin Endocrinol Metab (2008) 6.48

K+ channel mutations in adrenal aldosterone-producing adenomas and hereditary hypertension. Science (2011) 5.40

Prevalence of primary hyperaldosteronism in resistant hypertension: a retrospective observational study. Lancet (2008) 2.53

A novel form of human mendelian hypertension featuring nonglucocorticoid-remediable aldosteronism. J Clin Endocrinol Metab (2008) 2.48

Control of aldosterone secretion: a model for convergence in cellular signaling pathways. Physiol Rev (2004) 2.36

Primary aldosteronism: an update on screening, diagnosis and treatment. J Hypertens (2008) 2.35

Hypertension with or without adrenal hyperplasia due to different inherited mutations in the potassium channel KCNJ5. Proc Natl Acad Sci U S A (2012) 1.74

Hereditary hypertension caused by chimaeric gene duplications and ectopic expression of aldosterone synthase. Nat Genet (1992) 1.55

Stress-induced Aldosterone Hyper-Secretion in a Substantial Subset of Patients With Essential Hypertension. J Clin Endocrinol Metab (2015) 1.53

KCNJ5 mutations in European families with nonglucocorticoid remediable familial hyperaldosteronism. Hypertension (2011) 1.51

Role of KCNJ5 in familial and sporadic primary aldosteronism. Nat Rev Endocrinol (2012) 1.20

A novel point mutation in the KCNJ5 gene causing primary hyperaldosteronism and early-onset autosomal dominant hypertension. J Clin Endocrinol Metab (2012) 1.20

A lifetime of aldosterone excess: long-term consequences of altered regulation of aldosterone production for cardiovascular function. Endocr Rev (2008) 1.19

Glucocorticoid-remediable aldosteronism. Endocrinol Metab Clin North Am (2011) 1.01

Prevalence and characteristics of familial hyperaldosteronism: the PATOGEN study (Primary Aldosteronism in TOrino-GENetic forms). Hypertension (2011) 1.01

KCNJ5 mutations in the National Institutes of Health cohort of patients with primary hyperaldosteronism: an infrequent genetic cause of Conn's syndrome. Endocr Relat Cancer (2012) 0.96

Reciprocal influences between the signalling pathways regulating proliferation and steroidogenesis in adrenal glomerulosa cells. J Mol Endocrinol (2004) 0.94

Role of calcium and cAMP in the action of adrenocorticotropin on aldosterone secretion. J Biol Chem (1985) 0.93

A new form of hereditary primary aldosteronism: familial hyperaldosteronism type III. J Clin Endocrinol Metab (2008) 0.88

High prevalence of autonomous aldosterone secretion among patients with essential hypertension. Eur J Clin Invest (2011) 0.85

A new genetic test for familial hyperaldosteronism type I aids in the detection of curable hypertension. Biochem Biophys Res Commun (1995) 0.85

A diagnostic algorithm--the holy grail of primary aldosteronism. Nat Rev Endocrinol (2011) 0.84

Regulation of aldosterone biosynthesis by the Kir3.4 (KCNJ5) potassium channel. Clin Exp Pharmacol Physiol (2013) 0.78

Aldosterone secretory and glucocorticoid excretory responses to alpha 1-24 ACTH (Cortrosyn) in sodium-depleted normal man. J Clin Endocrinol Metab (1973) 0.77

Aldosterone synthase deficiency type II: an unusual presentation of the first Greek case reported with confirmed genetic analysis. Endocr Regul (2020) 0.75